Page 6 - 202016

Efficacy and Safety of Ubrogepant and Rimegepant in the Treatment of Acute Migraine：A Meta-analysis ……
……………… LIU Xin，ZHONG Xiaoyan，XU Changjing，FU Liya，TIAN Dongmei，YU Bin，HUANG Yilan（2018）
Effect and Practice of Sub-category Management of Chinese Patent Medicine in the Improvement of the Qualified
Rate for Outpatient Prescriptions of Chinese Patent Medicine ……………………………………………………
………………………………… CHEN Fei，LIU Yan，ZHUANG Wei，TANG Man，CUI Xiaohui，LIN Xiaolan（2023）
Analysis of Drug Therapy for a Case of Child with Human Herpesvirus 7 Infection in Central Nervous System
by Clinical Pharmacist …… SONG Mengjiao，WANG Limin，ZHANG Bin，DUAN Jinhai，ZHANG Xiaojuan（2029）

CHINA PHARMACY （Semimonthly） Postal Address
Founded in January 1990 129 Daping Main Street，Yuzhong District，Chongqing
Vol.31，No.16，Aug. 2020 400042，China
Total No.682 Published on Aug. 30，2020 Phone
Responsible Institution 86-23-63830521；86-23-63830907
National Health Commission，P.R. China E-mail
Sponsored by info@china-pharmacy.com
Chinese Hospital Association Website
Chongqing University Cancer Hospital http：//www.china-pharmacy.com
Edited by Online Submission
China Pharmacy Editorial and Publishing Center http：//2018.china-pharmacy.com
Director of Editorial Commission Printed by
LI Linkang Chongqing Changhong Printing Co.，Ltd.
Executive Deputy Director of Editorial Commission Distributed by
WU Yongzhong China：Chongqing Post Offices（Code No.78-33）
Honorary Editor-in-Chief Overseas：China International Book Trading Corporation
MA Jin （Code No.4703SM）
Editor-in-Chief Subscription Rates
HU Xin US $ 8.00 per issue；US $ 192.00 per annum
Vice Editor-in-Chief CSSN ISSN 1001-0408
LENG Huaiming CN 50-1055/R
Chief Editor CODEN
ZHANG Jian ZYHAA4
Published by Perennial Legal Counsel
China Pharmacy Editorial Department Chongqing Huali Wantao Law Firm